‘This is self-inflicted’: Leerink’s David Risinger on the market shock and hits to biopharma

As the markets continued to fall Monday in response to the Trump administration’s tariff proposals, biotech has particularly been hit hard. The industry was already being hammered by firings at the FDA ...